Literature DB >> 3296907

Molecular pharmacology of the monoamine transporter of the chromaffin granule membrane.

J P Henry, B Gasnier, M P Roisin, M F Isambert, D Scherman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3296907     DOI： 10.1111/j.1749-6632.1987.tb27201.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

1.  Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles.

Authors:  Prashant Mandela; Michelle Chandley; Yao-Yu Xu; Meng-Yang Zhu; Gregory A Ordway
Journal:  Neurochem Int       Date:  2010-02-20       Impact factor: 3.921

Review 2.  The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse.

Authors:  Justin R Nickell; Kiran B Siripurapu; Ashish Vartak; Peter A Crooks; Linda P Dwoskin
Journal:  Adv Pharmacol       Date:  2014

Review 3.  Vesicular neurotransmitter transporters. Potential sites for the regulation of synaptic function.

Authors:  H Varoqui; J D Erickson
Journal:  Mol Neurobiol       Date:  1997-10       Impact factor: 5.590

4.  Expression cloning of a reserpine-sensitive vesicular monoamine transporter.

Authors:  J D Erickson; L E Eiden; B J Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.